Solventum Corp. (SOLV)
89.08
+0.27
(+0.30%)
USD |
NYSE |
Nov 13, 16:00
89.56
+0.48
(+0.54%)
Pre-Market: 08:57
Solventum EPS Diluted (Quarterly) : -0.0703 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0703 |
| June 30, 2026 | 0.5309 |
| March 31, 2026 | 0.0741 |
| December 31, 2025 | 0.3586 |
| September 30, 2025 | 7.218 |
| June 30, 2025 | 0.5137 |
| March 31, 2025 | 0.7837 |
| December 31, 2024 | 0.1719 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.7016 |
| June 30, 2024 | 0.513 |
| March 31, 2024 | 1.372 |
| December 31, 2023 | 1.575 |
| September 30, 2023 | 2.664 |
| June 30, 2023 | 1.859 |
| March 31, 2023 | 1.696 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.038 |
| Edwards Lifesciences Corp. | 0.5324 |
| Intuitive Surgical, Inc. | 1.487 |
| Stryker Corp. | 1.957 |
| Inspire Medical Systems, Inc. | -0.8432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.00M |
| Revenue (Quarterly) | 1.949B |
| Total Expenses (Quarterly) | 1.961B |
| Enterprise Value | 19.96B |
| Gross Profit Margin (Quarterly) | 55.00% |
| Profit Margin (Quarterly) | -0.62% |
| Earnings Yield | 1.00% |
| Operating Earnings Yield | 4.41% |
| Normalized Earnings Yield | 2.27 |